{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:40:06Z","timestamp":1786740006091,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["54 \/01\/2020- HUM \/ BMS"],"award-info":[{"award-number":["54 \/01\/2020- HUM \/ BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jceh.2026.103616","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:51:47Z","timestamp":1784271107000},"page":"103616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in the Indian Ethnicity: An Update"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-0169","authenticated-orcid":false,"given":"Ravikanth","family":"Vishnubhotla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govardhan","family":"Bale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand V.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nageshwar Reddy","family":"Duvvur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2983-5768","authenticated-orcid":false,"given":"Nagaraja Rao","family":"Padaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2026.103616_bib1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jceh.2026.103616_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cld.1177","article-title":"Epidemiology of liver diseases in India","volume":"19","author":"Mondal","year":"2022","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2026.103616_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib5","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1038\/s41598-025-91312-5","article-title":"Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021","volume":"15","author":"Guo","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103616_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jceh.2026.103616_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2026.103616_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12944-025-02750-z","article-title":"The burden of NAFLD (now referred to as MASLD)-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India","volume":"24","author":"Zeng","year":"2025","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jceh.2026.103616_bib9","article-title":"Burden of MASLD and liver fibrosis: evidence from phenome India cohort","volume":"45","author":"Arvind","year":"2026","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.jceh.2026.103616_bib10","first-page":"76","article-title":"Non-alcoholic fatty liver disease in South Asians: a review of the literature","volume":"5","author":"Singh","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/jehp.jehp_208_23","article-title":"Evaluation of risk factors for non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Kannan","year":"2024","journal-title":"J Educ Health Promot"},{"key":"10.1016\/j.jceh.2026.103616_bib12","article-title":"Prevalence, metabolic profile, and associated risk factors of non-alcoholic fatty liver disease in an adult population of India","volume":"15","author":"Singhai","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2026.103616_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jceh.2015.09.001","article-title":"Risk factors associated with non-alcoholic fatty liver disease in Indians: a case-control study","volume":"5","author":"Singh","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib14","first-page":"277","article-title":"Monozygotic twins with NASH cirrhosis: cumulative effect of multiple single nucleotide polymorphisms?","volume":"15","author":"Grove","year":"2016","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib15","article-title":"P24 A genome-wide association study of non-alcoholic fatty liver disease in India: is there divergence in the genetic risk profile?","volume":"69","author":"Doshi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2026.103616_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145431","article-title":"Exome-wide scan identifies significant association of rs4788084 in IL27 promoter with increase in hepatic fat content among Indians","volume":"775","author":"Chatterjee","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.jceh.2026.103616_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jceh.2019.02.001","article-title":"Whole-exome sequencing identifies a variant in phosphatidylethanolamine N-Methyltransferase gene to be associated with lean-nonalcoholic fatty liver disease","volume":"9","author":"Bale","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib18","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.3390\/ijms23169296","article-title":"Hepatic PEMT expression decreases with increasing NAFLD severity","volume":"23","author":"Piras","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103616_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/jgh.16394","article-title":"Comparing rare variants versus common in the pathogenesis of nonalcoholic fatty liver disease: a whole exome sequencing approach","volume":"39","author":"Bale","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib20","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/jgh.16594","article-title":"The challenge of replicating putative genetic risk factors in a population-based database","volume":"39","author":"Nischalke","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101371","article-title":"17-Beta-Hydroxysteroid dehydrogenase 13 loss of function does not confer protection to nonalcoholic fatty liver disease in Indian population","volume":"14","author":"Govardhan","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib22","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jceh.2026.103616_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127902","article-title":"Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids","volume":"4","author":"Luukkonen","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jceh.2026.103616_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jceh.2026.103616_bib25","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A protein-truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103616_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3350\/cmh.2021.0301","article-title":"Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415825","article-title":"MTARC1 and HSD17B13 variants have protective effects on non-alcoholic fatty liver disease in patients undergoing bariatric surgery","volume":"23","author":"Kalinowski","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103616_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJMoa2117872","article-title":"Germline mutations in CIDEB and protection against liver disease","volume":"387","author":"Verweij","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103616_bib29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib30","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1038\/s41598-018-21939-0","article-title":"Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy","volume":"8","author":"Di Costanzo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2026.103616_bib31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jhep.2020.01.029","article-title":"A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank","volume":"72","author":"Walker","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/nu15010152","article-title":"Interaction between the PNPLA3 gene and nutritional factors on NAFLD development: the Korean genome and epidemiology study","volume":"15","author":"Oh","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2026.103616_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037827","article-title":"Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6\/omega3 PUFA intake","volume":"7","author":"Santoro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2026.103616_bib34","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00394-018-1675-4","article-title":"Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case-control study","volume":"58","author":"Kalafati","year":"2019","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jceh.2026.103616_bib35","first-page":"230","article-title":"Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort","volume":"S0168\u20138278","author":"Chen","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000441185","article-title":"Reduction of caloric intake might override the prosteatotic effects of the PNPLA3 p.I148M and TM6SF2 p.E167K variants in patients with fatty liver: ultrasound-based prospective study","volume":"93","author":"Krawczyk","year":"2016","journal-title":"Digestion"},{"key":"10.1016\/j.jceh.2026.103616_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2026.103616_bib38","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103616_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/liv.15533","article-title":"PNPLA3 I148M and response to treatment for hepatic steatosis: a systematic review","volume":"43","author":"Boeckmans","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2026.103616_bib40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/j.gastro.2023.11.018","article-title":"PNPLA3 risk allele association with ALT response to semaglutide treatment","volume":"166","author":"Urias","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103616_bib41","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.dld.2025.06.016","article-title":"Population stratification using MASLD polygenic risk score improves severe liver disease prediction by clinical fibrosis scores","volume":"57","author":"Liu","year":"2025","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2026.103616_bib42","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12967-024-05478-z","article-title":"Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes","volume":"22","author":"Xiao","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jceh.2026.103616_bib43","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","article-title":"Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Jamialahmadi","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2026.103616_bib44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4103\/ijcm.ijcm_437_22","article-title":"Prevalence of non-alcoholic fatty liver disease in urban adult population in a tertiary care center, chennai","volume":"48","author":"Anton","year":"2023","journal-title":"Indian J Community Med"},{"key":"10.1016\/j.jceh.2026.103616_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263768","article-title":"Rural-urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population","volume":"17:","author":"Asadullah","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2026.103616_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0019-557X.177295","article-title":"Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India","volume":"60","author":"Majumdar","year":"2016","journal-title":"Indian J Publ Health"},{"key":"10.1016\/j.jceh.2026.103616_bib47","first-page":"448","article-title":"Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)","volume":"61","author":"Kalra","year":"2013","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.jceh.2026.103616_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/ejim.ejim_76_18","article-title":"Prevalence of asymptomatic nonalcoholic fatty liver disease in nondiabetic participants: a study from South India","volume":"31","author":"Srinivasarao Bandaru","year":"2019","journal-title":"Egypt J Intern Med"},{"issue":"5","key":"10.1016\/j.jceh.2026.103616_bib49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/jdi.13411","article-title":"Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus","volume":"12","author":"Kubihal","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jceh.2026.103616_bib50","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s13312-017-1202-3","article-title":"Prevalence of nonalcoholic fatty liver disease in normal-weight and overweight preadolescent children in Haryana, India","volume":"54","author":"Das","year":"2017","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jceh.2026.103616_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7869\/tg.241","article-title":"Non-alcoholic fatty liver disease prevalence and associated risk factors--A study from rural sector of Maharashtra","volume":"36","author":"Anurag","year":"2015","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103616_bib52","first-page":"76","article-title":"Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey","volume":"25","author":"Singh","year":"2004","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103616_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diabres.2008.11.039","article-title":"Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome","volume":"84","author":"Mohan","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jceh.2026.103616_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jgh3.12117","article-title":"High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India","volume":"3","author":"Duseja","year":"2019","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2026.103616_bib55","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.18203\/2349-3291.ijcp20171726","article-title":"Prevalence of non-alcoholic fatty liver disease among obese children in North Kerala, India","volume":"4","author":"Reetha","year":"2017","journal-title":"Int J Contemp Pediatr"},{"key":"10.1016\/j.jceh.2026.103616_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpb.2019.10.2087","article-title":"Prevalence of NAFLD among nursing staff in a medical Institute in South India - a cross sectional study","volume":"21","author":"Vishnu Prasad","year":"2019","journal-title":"HPB"},{"key":"10.1016\/j.jceh.2026.103616_bib57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/met.2012.0064","article-title":"Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease","volume":"11","author":"Bhatt","year":"2013","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jceh.2026.103616_bib58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4254\/wjh.v6.i6.435","article-title":"Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: a pilot study","volume":"6","author":"Kanth","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib59","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4254\/wjh.v9.i26.1101","article-title":"Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities","volume":"9","author":"Bale","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2026.103616_bib60","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1016\/j.cgh.2016.09.097","article-title":"PNPLA3 gene polymorphisms and the associated risk of non-alcoholic fatty liver disease in Indian subjects","volume":"15","author":"Vernekar","year":"2017","journal-title":"Clinical Gastro Hep"},{"key":"10.1016\/j.jceh.2026.103616_bib61","article-title":"Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in North India","volume":"13","author":"Bhatt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2026.103616_bib62","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1515\/jpem-2018-0543","article-title":"Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents","volume":"32","author":"Jain","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jceh.2026.103616_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3160","article-title":"Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population","volume":"22","author":"Narayanasamy","year":"2020","journal-title":"J Gene Med"},{"key":"10.1016\/j.jceh.2026.103616_bib64","first-page":"123","article-title":"Association of genetic variants in the PRomoter region of APOC3 with the risk of non-alcoholic fatty liver disease (NAFLD) in north Indian population","volume":"13","author":"Ahmed","year":"2022","journal-title":"J Adv Sci Res"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:39:11Z","timestamp":1786736351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688326001489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0973688326001489"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103616","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in the Indian Ethnicity: An Update","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103616"}}